Quality of life analysis of patients undergoing immunotherapy for allergic rhinitis.

@article{Fell1997QualityOL,
  title={Quality of life analysis of patients undergoing immunotherapy for allergic rhinitis.},
  author={W R Fell and Richard L Mabry and C S Mabry},
  journal={Ear, nose, & throat journal},
  year={1997},
  volume={76 8},
  pages={528-32, 534-6}
}
Allergic rhinitis has been conservatively estimated to affect 35 million Americans, with an annual US expenditure of more than $2 billion for treatment. Immunotherapy is generally administered to patients with allergic rhinitis when avoidance is impossible or impractical, when pharmacotherapy provides insufficient relief, and/or symptoms span more than one season. Immunotherapy based on quantified testing (e.g., dilutional intradermal testing [SET] or in vitro methods [RAST, ELISA]) allows… CONTINUE READING
Highly Cited
This paper has 20 citations. REVIEW CITATIONS